rs41307461

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_033305.3(VPS13A):​c.775A>G​(p.Asn259Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,613,546 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 24 hom. )

Consequence

VPS13A
NM_033305.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:10

Conservation

PhyloP100: 2.06

Publications

6 publications found
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
  • chorea-acanthocytosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0078703165).
BP6
Variant 9-77219974-A-G is Benign according to our data. Variant chr9-77219974-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 367346.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00249 (379/152168) while in subpopulation NFE AF = 0.00447 (304/67962). AF 95% confidence interval is 0.00406. There are 1 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033305.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
NM_033305.3
MANE Select
c.775A>Gp.Asn259Asp
missense
Exon 11 of 72NP_150648.2Q96RL7-1
VPS13A
NM_001018037.2
c.775A>Gp.Asn259Asp
missense
Exon 11 of 71NP_001018047.1Q96RL7-3
VPS13A
NM_015186.4
c.775A>Gp.Asn259Asp
missense
Exon 11 of 69NP_056001.1Q96RL7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
ENST00000360280.8
TSL:1 MANE Select
c.775A>Gp.Asn259Asp
missense
Exon 11 of 72ENSP00000353422.3Q96RL7-1
VPS13A
ENST00000376636.7
TSL:1
c.775A>Gp.Asn259Asp
missense
Exon 11 of 71ENSP00000365823.3Q96RL7-3
VPS13A
ENST00000643348.1
c.775A>Gp.Asn259Asp
missense
Exon 11 of 69ENSP00000493592.1Q96RL7-2

Frequencies

GnomAD3 genomes
AF:
0.00249
AC:
379
AN:
152050
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000990
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00239
AC:
601
AN:
251160
AF XY:
0.00220
show subpopulations
Gnomad AFR exome
AF:
0.000432
Gnomad AMR exome
AF:
0.000550
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00428
Gnomad OTH exome
AF:
0.00327
GnomAD4 exome
AF:
0.00379
AC:
5535
AN:
1461378
Hom.:
24
Cov.:
31
AF XY:
0.00358
AC XY:
2600
AN XY:
726990
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33456
American (AMR)
AF:
0.000693
AC:
31
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
98
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86228
European-Finnish (FIN)
AF:
0.00140
AC:
75
AN:
53410
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5764
European-Non Finnish (NFE)
AF:
0.00459
AC:
5099
AN:
1111684
Other (OTH)
AF:
0.00335
AC:
202
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
275
549
824
1098
1373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00249
AC:
379
AN:
152168
Hom.:
1
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.000987
AC:
41
AN:
41550
American (AMR)
AF:
0.000393
AC:
6
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00447
AC:
304
AN:
67962
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00318
Hom.:
0
Bravo
AF:
0.00220
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00265
AC:
322
EpiCase
AF:
0.00387
EpiControl
AF:
0.00350

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
7
not provided (8)
-
2
2
Chorea-acanthocytosis (4)
-
-
1
VPS13A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.0079
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
2.1
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.063
Sift
Benign
0.12
T
Sift4G
Benign
0.43
T
Polyphen
0.0040
B
Vest4
0.21
MVP
0.45
MPC
0.15
ClinPred
0.0065
T
GERP RS
-0.0091
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.38
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41307461; hg19: chr9-79834890; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.